15 May 2020 SARS-COV-2 Neutralising Affimers – Potential for a COVID-19 Therapy Investors | Reagents & Diagnostics | Therapeutics
12 Feb 2020 Alastair Smith provides overview of pre|CISION™ prodrug technology and update on AVA6000 clinical trial Investors | Therapeutics
03 Feb 2020 Avacta and Daewoong Agree Collaboration and License Agreement with AffyXell Therapeutics News | Therapeutics
28 Jan 2020 Successful initial proof-of-concept for a proprietary new class of anti-cancer therapy Investors | Therapeutics
08 Jan 2020 Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture Investors | News | Therapeutics